TS-ONE OD Tablet 20

Manufacturer
Taiho Pharmaceutical Co.,Ltd.(JAPAN)

Registraction Number
MAL19071004AZ

Content:

• Active Ingredients: Tegafur (20 mg), Gimeracil (5.8 mg), Oteracil potassium (19.6 mg)

• Advanced gastric cancer when given in combination with cisplatin
• Locally advanced gastric cancer (stage II (excluding T1), IIIA, or IIIB) as post-operative adjuvant chemotherapy
• Locally advanced or metastatic pancreatic cancer as monotherapy
• Locally advanced or metastatic non-small cell lung cancer when given in combination with carboplatin
• Metastatic colorectal cancer when given in combination with oxaliplatin as first-line treatment or with irinotecan as second-line treatment
• HER2-negative metastatic breast cancer as monotherapy

• Dosage: The dosage and administration schedule should be determined by your healthcare provider based on your specific condition and medical history. The standard dose is based on body surface area (BSA) and may differ between Asian and Caucasian populations.
• Administration: Take the tablet orally as directed by your healthcare provider. It is important to follow the prescribed dosing schedule and any additional instructions provided by your doctor.